International Biophysics, the maker of AffloVest, announced that it is continuing to support people with cystic fibrosis and…
Articles by Vijaya Iyer, PhD
The Cystic Fibrosis Foundation (CFF) recognized CARSTAR — the largest franchise network of auto body repair service in…
Synspira Therapeutics’s candidate for treating cystic fibrosis, SNSP113, has received orphan drug designation from the European Medicines’…
Blocking the enzyme cathepsin S can alleviate symptoms and reduce lung damage in cystic fibrosis (CF) and chronic obstructive…
ContraFect will receive up to $6.94 million in funding from CARB-X to support the development of their proprietary therapeutic…
MaRS Innovation recently announced the launch of two new projects targeting the development of new therapeutics for cystic…
NetNoggin has launched a new cystic fibrosis (CF) market research report to highlight patient and caregiver experiences and their…
Emily’s Hope and Cisco have raised more than $1 million as part of Great Strides – a Cystic…
Enrollment for a Phase 3 clinical trial testing AeroVanc in patients with cystic fibrosis with methicillin-resistant Staphylococcus aureus (MRSA) lung…
A reassessment of U.K. medical records showed that in cystic fibrosis (CF) patients, breathing support provided by gas inhalation,…